{"entity":{"type":"insider","cik":"0001309702","url":"/insider/0001309702","json_url":"/insider/0001309702.json","name":"HASTINGS PAUL J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":56,"n_filings":41,"first":"2005-04-29","last":"2026-06-22","span_basis":"filed_date"},"name_variants":[{"name":"HASTINGS PAUL J","source":"filing","n_filings":41,"first_seen":"2005-04-29","last_seen":"2026-06-22"}],"transactions":[{"id":5944305,"accession":"0001193125-26-277507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-277507","line_url":"/filing/0001193125-26-277507#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1776.0,"shares_display":"1,776","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":4812.96,"total_display":"4,812.96","shares_owned_after":390247.0,"shares_owned_after_display":"390,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-18","filed_date":"2026-06-22","scope":"insider"},{"id":6035883,"accession":"0001193125-26-016865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-016865","line_url":"/filing/0001193125-26-016865#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26046.0,"shares_display":"26,046","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":53915.22,"total_display":"53,915.22","shares_owned_after":390023.0,"shares_owned_after_display":"390,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider"},{"id":4027810,"accession":"0000950170-25-088501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-088501","line_url":"/filing/0000950170-25-088501#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1790.0,"shares_display":"1,790","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":3204.1,"total_display":"3,204.10","shares_owned_after":320069.0,"shares_owned_after_display":"320,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-20","scope":"insider"},{"id":4524800,"accession":"0000950170-25-006824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-006824","line_url":"/filing/0000950170-25-006824#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17378.0,"shares_display":"17,378","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":38231.6,"total_display":"38,231.60","shares_owned_after":319859.0,"shares_owned_after_display":"319,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider"},{"id":2117090,"accession":"0000950170-24-075732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-075732","line_url":"/filing/0000950170-24-075732#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1770.0,"shares_display":"1,770","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":9912.0,"total_display":"9,912.00","shares_owned_after":240737.0,"shares_owned_after_display":"240,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":2250928,"accession":"0001396814-24-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001396814-24-000075","line_url":"/filing/0001396814-24-000075#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":880.0,"shares_display":"880","price_per_share":28.38,"price_display":"28.38","price_state":"stated","total_value":24974.4,"total_display":"24,974.40","shares_owned_after":12724.0,"shares_owned_after_display":"12,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-13","scope":"insider"},{"id":3070791,"accession":"0000950170-24-005426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-005426","line_url":"/filing/0000950170-24-005426#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9697.0,"shares_display":"9,697","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":84751.78,"total_display":"84,751.78","shares_owned_after":390507.0,"shares_owned_after_display":"390,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":7835720,"accession":"0001209191-23-039051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-039051","line_url":"/filing/0001209191-23-039051#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1704.0,"shares_display":"1,704","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":8264.4,"total_display":"8,264.40","shares_owned_after":313402.0,"shares_owned_after_display":"313,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":7954114,"accession":"0001209191-23-035257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035257","line_url":"/filing/0001209191-23-035257#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":580.0,"shares_display":"580","price_per_share":38.339,"price_display":"38.34","price_state":"stated","total_value":22236.62,"total_display":"22,236.62","shares_owned_after":6599.0,"shares_owned_after_display":"6,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":8703064,"accession":"0001209191-23-030141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-030141","line_url":"/filing/0001209191-23-030141#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":41.85,"price_display":"41.85","price_state":"stated","total_value":292950.0,"total_display":"292,950.00","shares_owned_after":7179.0,"shares_owned_after_display":"7,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":8605323,"accession":"0001209191-23-003853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003853","line_url":"/filing/0001209191-23-003853#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3691.0,"shares_display":"3,691","price_per_share":5.49,"price_display":"5.49","price_state":"stated","total_value":20263.59,"total_display":"20,263.59","shares_owned_after":313106.0,"shares_owned_after_display":"313,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-18","scope":"insider"},{"id":6140382,"accession":"0000899243-22-032306","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-032306","line_url":"/filing/0000899243-22-032306#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":498.0,"shares_display":"498","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":6474.0,"total_display":"6,474.00","shares_owned_after":250461.0,"shares_owned_after_display":"250,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-09-30","scope":"insider"},{"id":6140379,"accession":"0000899243-22-032306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-032306","line_url":"/filing/0000899243-22-032306#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23376.0,"shares_display":"23,376","price_per_share":13.0311,"price_display":"13.03","price_state":"stated","total_value":304614.9936,"total_display":"304,614.99","shares_owned_after":250959.0,"shares_owned_after_display":"250,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-30","scope":"insider"},{"id":6364890,"accession":"0000899243-22-031711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-031711","line_url":"/filing/0000899243-22-031711#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6126.0,"shares_display":"6,126","price_per_share":13.0129,"price_display":"13.01","price_state":"stated","total_value":79717.0254,"total_display":"79,717.03","shares_owned_after":274335.0,"shares_owned_after_display":"274,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-22","scope":"insider"},{"id":6892713,"accession":"0001209191-22-042037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042037","line_url":"/filing/0001209191-22-042037#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":533.0,"shares_display":"533","price_per_share":56.95,"price_display":"56.95","price_state":"stated","total_value":30354.35,"total_display":"30,354.35","shares_owned_after":7179.0,"shares_owned_after_display":"7,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-11","filed_date":"2022-07-13","scope":"insider"},{"id":5395766,"accession":"0000899243-21-038637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-038637","line_url":"/filing/0000899243-21-038637#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8277.0,"shares_display":"8,277","price_per_share":27.2,"price_display":"27.20","price_state":"stated","total_value":225134.4,"total_display":"225,134.40","shares_owned_after":219284.0,"shares_owned_after_display":"219,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-29","filed_date":"2021-10-01","scope":"insider"},{"id":5395764,"accession":"0000899243-21-038637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-038637","line_url":"/filing/0000899243-21-038637#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223.0,"shares_display":"223","price_per_share":26.53,"price_display":"26.53","price_state":"stated","total_value":5916.19,"total_display":"5,916.19","shares_owned_after":219061.0,"shares_owned_after_display":"219,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-29","filed_date":"2021-10-01","scope":"insider"},{"id":5364047,"accession":"0000899243-21-025505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-025505","line_url":"/filing/0000899243-21-025505#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4693.0,"shares_display":"4,693","price_per_share":26.39,"price_display":"26.39","price_state":"stated","total_value":123848.27,"total_display":"123,848.27","shares_owned_after":231368.0,"shares_owned_after_display":"231,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-23","scope":"insider"},{"id":5364042,"accession":"0000899243-21-025505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-025505","line_url":"/filing/0000899243-21-025505#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3807.0,"shares_display":"3,807","price_per_share":26.89,"price_display":"26.89","price_state":"stated","total_value":102370.23,"total_display":"102,370.23","shares_owned_after":227561.0,"shares_owned_after_display":"227,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-23","scope":"insider"},{"id":4140183,"accession":"0001209191-21-038878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038878","line_url":"/filing/0001209191-21-038878#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":630.0,"shares_display":"630","price_per_share":62.19,"price_display":"62.19","price_state":"stated","total_value":39179.7,"total_display":"39,179.70","shares_owned_after":5486.0,"shares_owned_after_display":"5,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-08","scope":"insider"},{"id":5455075,"accession":"0000899243-21-014312","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-014312","line_url":"/filing/0000899243-21-014312#line-3","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11461.0,"shares_display":"11,461","price_per_share":30.23,"price_display":"30.23","price_state":"stated","total_value":346466.03,"total_display":"346,466.03","shares_owned_after":241600.0,"shares_owned_after_display":"241,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"},{"id":5455071,"accession":"0000899243-21-014312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-014312","line_url":"/filing/0000899243-21-014312#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3130.0,"shares_display":"3,130","price_per_share":32.21,"price_display":"32.21","price_state":"stated","total_value":100817.3,"total_display":"100,817.30","shares_owned_after":236061.0,"shares_owned_after_display":"236,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"},{"id":5455068,"accession":"0000899243-21-014312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-014312","line_url":"/filing/0000899243-21-014312#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2409.0,"shares_display":"2,409","price_per_share":31.24,"price_display":"31.24","price_state":"stated","total_value":75257.16,"total_display":"75,257.16","shares_owned_after":239191.0,"shares_owned_after_display":"239,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"},{"id":5520994,"accession":"0001209191-21-018946","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018946","line_url":"/filing/0001209191-21-018946#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":65.88,"price_display":"65.88","price_state":"stated","total_value":197640.0,"total_display":"197,640.00","shares_owned_after":6116.0,"shares_owned_after_display":"6,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":2544694,"accession":"0001209191-20-035170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-035170","line_url":"/filing/0001209191-20-035170#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2025.0,"shares_display":"2,025","price_per_share":47.46,"price_display":"47.46","price_state":"stated","total_value":96106.5,"total_display":"96,106.50","shares_owned_after":4856.0,"shares_owned_after_display":"4,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider"},{"id":7979031,"accession":"0001209191-19-035086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-035086","line_url":"/filing/0001209191-19-035086#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":782.0,"shares_display":"782","price_per_share":42.66,"price_display":"42.66","price_state":"stated","total_value":33360.12,"total_display":"33,360.12","shares_owned_after":2747.0,"shares_owned_after_display":"2,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider"},{"id":6336191,"accession":"0001209191-18-036181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-036181","line_url":"/filing/0001209191-18-036181#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":771.0,"shares_display":"771","price_per_share":33.9,"price_display":"33.90","price_state":"stated","total_value":26136.9,"total_display":"26,136.90","shares_owned_after":2747.0,"shares_owned_after_display":"2,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-04","filed_date":"2018-06-06","scope":"insider"},{"id":4189948,"accession":"0001140361-17-038567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-038567","line_url":"/filing/0001140361-17-038567#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1346.0,"shares_display":"1,346","price_per_share":4.2418,"price_display":"4.24","price_state":"stated","total_value":5709.4628,"total_display":"5,709.46","shares_owned_after":76188.0,"shares_owned_after_display":"76,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-12","scope":"insider"},{"id":4189946,"accession":"0001140361-17-038567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-038567","line_url":"/filing/0001140361-17-038567#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52.0,"shares_display":"52","price_per_share":4.2611,"price_display":"4.26","price_state":"stated","total_value":221.5772,"total_display":"221.58","shares_owned_after":77534.0,"shares_owned_after_display":"77,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-12","scope":"insider"},{"id":4629661,"accession":"0001209191-17-050231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-050231","line_url":"/filing/0001209191-17-050231#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1044.0,"shares_display":"1,044","price_per_share":36.15,"price_display":"36.15","price_state":"stated","total_value":37740.6,"total_display":"37,740.60","shares_owned_after":3518.0,"shares_owned_after_display":"3,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-22","filed_date":"2017-08-24","scope":"insider"},{"id":4089165,"accession":"0001140361-17-015045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-015045","line_url":"/filing/0001140361-17-015045#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6425.0,"shares_display":"6,425","price_per_share":9.0582,"price_display":"9.06","price_state":"stated","total_value":58198.935,"total_display":"58,198.94","shares_owned_after":32586.0,"shares_owned_after_display":"32,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider"},{"id":4089162,"accession":"0001140361-17-015045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-015045","line_url":"/filing/0001140361-17-015045#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48.0,"shares_display":"48","price_per_share":8.8671,"price_display":"8.87","price_state":"stated","total_value":425.6208,"total_display":"425.62","shares_owned_after":39011.0,"shares_owned_after_display":"39,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider"},{"id":4456717,"accession":"0001140361-17-001260","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-001260","line_url":"/filing/0001140361-17-001260#line-4","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21369.0,"shares_display":"21,369","price_per_share":8.515,"price_display":"8.52","price_state":"stated","total_value":181957.035,"total_display":"181,957.04","shares_owned_after":37323.0,"shares_owned_after_display":"37,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-06","filed_date":"2017-01-09","scope":"insider"},{"id":4456708,"accession":"0001140361-17-001260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-001260","line_url":"/filing/0001140361-17-001260#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21369.0,"shares_display":"21,369","price_per_share":8.1708,"price_display":"8.17","price_state":"stated","total_value":174601.8252,"total_display":"174,601.83","shares_owned_after":37323.0,"shares_owned_after_display":"37,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-05","filed_date":"2017-01-09","scope":"insider"},{"id":2564112,"accession":"0001140361-16-069148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-069148","line_url":"/filing/0001140361-16-069148#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Relypsa Inc","issuer_ticker":"RLYP","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1013.0,"shares_display":"1,013","price_per_share":19.3218,"price_display":"19.32","price_state":"stated","total_value":19572.9834,"total_display":"19,572.98","shares_owned_after":2495.0,"shares_owned_after_display":"2,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-08","scope":"insider"},{"id":3127901,"accession":"0001209191-16-126649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-126649","line_url":"/filing/0001209191-16-126649#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1136.0,"shares_display":"1,136","price_per_share":46.95,"price_display":"46.95","price_state":"stated","total_value":53335.2,"total_display":"53,335.20","shares_owned_after":1717.0,"shares_owned_after_display":"1,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-08","scope":"insider"},{"id":2730178,"accession":"0001209191-16-101142","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-101142","line_url":"/filing/0001209191-16-101142#line-3","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","shares_owned_after":2853.0,"shares_owned_after_display":"2,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-22","scope":"insider"},{"id":2285284,"accession":"0001140361-16-047336","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-047336","line_url":"/filing/0001140361-16-047336#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2335.0,"shares_display":"2,335","price_per_share":22.3006,"price_display":"22.30","price_state":"stated","total_value":52071.901,"total_display":"52,071.90","shares_owned_after":22102.0,"shares_owned_after_display":"22,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-06","filed_date":"2016-01-08","scope":"insider"},{"id":2285280,"accession":"0001140361-16-047336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-047336","line_url":"/filing/0001140361-16-047336#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77.0,"shares_display":"77","price_per_share":21.5425,"price_display":"21.54","price_state":"stated","total_value":1658.7725,"total_display":"1,658.77","shares_owned_after":22025.0,"shares_owned_after_display":"22,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-06","filed_date":"2016-01-08","scope":"insider"},{"id":8227872,"accession":"0001209191-15-082084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-082084","line_url":"/filing/0001209191-15-082084#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","shares_owned_after":2853.0,"shares_owned_after_display":"2,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-20","filed_date":"2015-11-24","scope":"insider"},{"id":8867112,"accession":"0001209191-15-067013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-067013","line_url":"/filing/0001209191-15-067013#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":60.02,"price_display":"60.02","price_state":"stated","total_value":180060.0,"total_display":"180,060.00","shares_owned_after":2853.0,"shares_owned_after_display":"2,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider"},{"id":8699397,"accession":"0001140361-15-024344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-024344","line_url":"/filing/0001140361-15-024344#line-1","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Relypsa Inc","issuer_ticker":"RLYP","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1454.0,"shares_display":"1,454","price_per_share":34.6349,"price_display":"34.63","price_state":"stated","total_value":50359.1446,"total_display":"50,359.14","shares_owned_after":3508.0,"shares_owned_after_display":"3,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-15","scope":"insider"},{"id":8057623,"accession":"0001181431-15-005801","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-005801","line_url":"/filing/0001181431-15-005801#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":88.0,"price_display":"88.00","price_state":"stated","total_value":220000.0,"total_display":"220,000.00","shares_owned_after":853.0,"shares_owned_after_display":"853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-10","filed_date":"2015-04-14","scope":"insider"},{"id":8739652,"accession":"0001181431-15-000939","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-000939","line_url":"/filing/0001181431-15-000939#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":94.06,"price_display":"94.06","price_state":"stated","total_value":235150.0,"total_display":"235,150.00","shares_owned_after":853.0,"shares_owned_after_display":"853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-14","scope":"insider"},{"id":6969743,"accession":"0001140361-14-039584","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-14-039584","line_url":"/filing/0001140361-14-039584#line-4","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8385.0,"shares_display":"8,385","price_per_share":21.8984,"price_display":"21.90","price_state":"stated","total_value":183618.084,"total_display":"183,618.08","shares_owned_after":23231.0,"shares_owned_after_display":"23,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-29","filed_date":"2014-10-30","scope":"insider"},{"id":6969736,"accession":"0001140361-14-039584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-039584","line_url":"/filing/0001140361-14-039584#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8384.0,"shares_display":"8,384","price_per_share":22.0806,"price_display":"22.08","price_state":"stated","total_value":185123.7504,"total_display":"185,123.75","shares_owned_after":23231.0,"shares_owned_after_display":"23,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-28","filed_date":"2014-10-30","scope":"insider"},{"id":7067126,"accession":"0001181431-14-034260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-034260","line_url":"/filing/0001181431-14-034260#line-2","is_derivative":false,"issuer_cik":"0001309702","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001309702","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":94.87,"price_display":"94.87","price_state":"stated","total_value":237175.0,"total_display":"237,175.00","shares_owned_after":853.0,"shares_owned_after_display":"853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-10","filed_date":"2014-10-14","scope":"insider"},{"id":6377397,"accession":"0001140361-14-030004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-14-030004","line_url":"/filing/0001140361-14-030004#line-5","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8385.0,"shares_display":"8,385","price_per_share":22.2781,"price_display":"22.28","price_state":"stated","total_value":186801.8685,"total_display":"186,801.87","shares_owned_after":22500.0,"shares_owned_after_display":"22,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-29","filed_date":"2014-07-30","scope":"insider"},{"id":6377390,"accession":"0001140361-14-030004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-14-030004","line_url":"/filing/0001140361-14-030004#line-3","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8285.0,"shares_display":"8,285","price_per_share":21.9271,"price_display":"21.93","price_state":"stated","total_value":181666.0235,"total_display":"181,666.02","shares_owned_after":22600.0,"shares_owned_after_display":"22,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-28","filed_date":"2014-07-30","scope":"insider"},{"id":6377387,"accession":"0001140361-14-030004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-030004","line_url":"/filing/0001140361-14-030004#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001309702","owner_name":"HASTINGS PAUL J","owner_url":"/insider/0001309702","role":"Director, Officer (Chairman & CEO)","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":22.7,"price_display":"22.70","price_state":"stated","total_value":2270.0,"total_display":"2,270.00","shares_owned_after":22500.0,"shares_owned_after_display":"22,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-28","filed_date":"2014-07-30","scope":"insider"}],"next_cursor":"2014-07-28|6377387","ledger_fault":false,"count":{"value":56,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":54,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":56},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001787400","name":"Nkarta, Inc.","url":"/issuer/0001787400","role":"Director, Officer (Chief Executive Officer)","n_filings":13,"first_seen":"2021-04-01","last_seen":"2026-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira BioSciences, Inc.","url":"/issuer/0001396814","role":"Director","n_filings":19,"first_seen":"2013-05-17","last_seen":"2024-06-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Director, Officer (Chairman & CEO)","n_filings":6,"first_seen":"2014-07-30","last_seen":"2017-10-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001416792","name":"Relypsa Inc","url":"/issuer/0001416792","role":"Director","n_filings":2,"first_seen":"2015-06-15","last_seen":"2016-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000827809","name":"QLT INC/BC","url":"/issuer/0000827809","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2005-04-29","last_seen":"2005-04-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001309702","retrieved_at":"2026-08-21T07:19:44+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}